Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01524770 · ClinicalTrials.gov registry record · Phase 1
A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT01524770 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 50 participants.
The verdict
NCT01524770, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study involves 2 injections of 1.5 milligrams (mg) dulaglutide, 1 given by a pre-filled manual syringe, the other given by an auto-injector. Injections will be separated by a minimum 28-day washout period. The study will evaluate if the levels of drug in the blood are similar when given by each method. Participation in the study is likely to take approximately 7 weeks, not including screening.
Interventions
- BIOLOGICAL Dulaglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01524770
The ClinicalTrials.gov registry entry for NCT01524770 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dulaglutide is the first listed.
NCT01524770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01524770 about?
NCT01524770 is a clinical study titled "A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe". The study involves 2 injections of 1.5 milligrams (mg) dulaglutide, 1 given by a pre-filled manual syringe, the other given by an auto-injector. Injections will be separated by a minimum 28-day washout period. The study will evaluate if the levels of drug in the blood are similar when given by each ...
What is the current status of trial NCT01524770?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2012-03. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01524770?
The interventions under investigation include: Dulaglutide (BIOLOGICAL).
Who is sponsoring clinical trial NCT01524770?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.